Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with <scp>EGFR G719X</scp>/<scp>L861Q</scp>/<scp>S768I</scp>

PaperCitations, authors & open-access status

Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with <scp>EGFR G719X</scp>/<scp>L861Q</scp>/<scp>S768I</scp> is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 24 citations, 2022 year and closed oa status.

24
Citations
2022
Year
closed
OA Status

Related on ScholarIQ

Lanlan Pang
Author
Cancer
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Diagnosis and Treatment
Topic
Colorectal Cancer Treatments and Studies
Topic
470M+ articles · free account